Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer’s disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.